Efficacy of Tezepelumab in Patients with Moderate-to-Severe, Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies

被引：0
|
作者：
Ambrose, Chris [1 ]
Menzies-Gow, Andrew [2 ]
Cook, Bill [1 ]
Hellqvist, Asa [3 ]
Roseti, Stephanie [4 ]
Molfino, Nestor [5 ]
Llanos-Ackert, Jean-Pierre [6 ]
Colice, Gene [4 ]
Corren, Jonathan [7 ]
机构：
[1] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gaithersburg, MD USA
[2] Royal Brompton Hosp, London, England
[3] AstraZeneca, Biometr, Late Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden
[4] AstraZeneca, Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA
[5] Amgen Inc, Global Dev, Thousand Oaks, CA USA
[6] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2022年 / 149卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
044
引用
收藏
页码：AB16 / AB16
页数：1
相关论文
共 50 条
  • [1] Efficacy of Tezepelumab in Patients with Moderate-to-Severe Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies
    Corren, J.
    Menzies-Gow, A.
    Ambrose, C.
    Cook, W.
    Hellquist, A.
    Roseti, S.
    Molfinao, N.
    Lanos-Ackert, P. J.
    Colice, G.
    [J]. PNEUMOLOGIE, 2022, 76 : S14 - S14
  • [2] Incidence Of Infections In Patients With Severe, Uncontrolled Asthma Treated With Tezepelumab: A Pooled Analysis Of The Phase 2b PATHWAY And Phase 3 NAVIGATOR Studies
    Menzies-Gow, Andrew
    Corren, Jonathan
    Ambrose, Chris
    Hunter, Gillian
    Fitzpatrick, Sherahe
    Hagberg, Anette
    Ponnarambil, Sandhia
    Martin, Neil
    Molfino, Nestor
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB16 - AB16
  • [3] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES
    Corren, Jonathan
    Wechsler, Michael E.
    Chupp, Geoffrey L.
    Ambrose, Christopher
    Roseti, Stephanie L.
    Hellqvist, Asa
    Ackert, Jean-Pierre Llanos
    Martin, Neil
    Colice, Gene L.
    [J]. CHEST, 2022, 162 (04) : 21A - 22A
  • [4] Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials
    Corren, Jonathan
    Menzies-Gow, Andrew
    Chupp, Geoffrey
    Israel, Elliot
    Korn, Stephanie
    Cook, Bill
    Ambrose, Christopher S.
    Hellqvist, Asa
    Roseti, Stephanie L.
    Molfino, Nestor A.
    Llanos, Jean-Pierre
    Martin, Neil
    Bowen, Karin
    Griffiths, Janet M.
    Parnes, Jane R.
    Colice, Gene
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (01) : 13 - 24
  • [5] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH COMORBID GASTROESOPHAGEAL REFLUX DISEASE: A POOLED ANALYSIS OF THE PATHWAY AND NAVIGATOR STUDIES
    Moore, Wendy C.
    Lugogo, Njira L.
    Chupp, Geoffrey L.
    Martin, Nicole
    Ambrose, Christopher
    Cook, William
    Ackert, Jean-Pierre Llanos
    [J]. CHEST, 2023, 164 (04) : 4A - 7A
  • [6] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
    Emson, Claire
    Corren, Jonathan
    Salapa, Kinga
    Hellqvist, Asa
    Parnes, Jane R.
    Colice, Gene
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 91 - 99
  • [7] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [8] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY
    Castro, Mario
    Cook, William
    Ambrose, Christopher
    Lindsley, Andrew W.
    Hunter, Gillian
    Martin, Neil
    Ponnarambil, Sandhia
    [J]. CHEST, 2022, 162 (04) : 35A - 36A
  • [9] TEZEPELUMAB REDUCES MUCUS PLUGGING IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: THE PHASE 2 CASCADE STUDY
    Nordenrnark, L.
    Emson, C.
    Hellqvist, A.
    Johnston, J.
    Greberg, H.
    Griffiths, J. M.
    Newell, J. D.
    Pames, J. R.
    Colice, G.
    Brightling, C. E.
    [J]. THORAX, 2022, 77 : A32 - A32
  • [10] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
    Carr, Tara
    Bernstein, Jonathan
    Cook, Bill
    Hunter, Gillian
    Ambrose, Chris
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
12345